Duchenne Muscular Dystrophy: Modern Approaches in Patient Management
Duchenne muscular dystrophy is one of the most common forms of childhood muscular dystrophies. Its incidence is 1 in 3.5-6 thousand newborn boys according to various sources. The disease is caused by the mutation in the DMD gene coding the dystrophin protein, it leads to the dystrophin absence or ma...
Saved in:
Similar Items
-
Immunomodulating effects of tofizopam (Grandaxin®) and diazepam in vitro
by: Sergey V. Kalashnikov, et al.
Published: (2002) -
Effect of Rehabilitation Interventions on Post-Stroke Upper Limb Dysfunction and Cognitive Functions: a Systematic Review and Meta-Analysis
by: Elena V. Kostenko, et al.
Published: (2023) -
Specificity of Russian Teenager's Civic Identity (Case of Campers at the Artek International Children's Centre)
by: Elena V. Belovol, et al.
Published: (2022) -
Remote Monitoring of Cardiovascular Risks of Medical Rehabilitation of Ischemic Stroke Patients Using Information and Telecommunication Systems
by: Elena V. Kostenko, et al.
Published: (2023) -
CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene
by: Tatiana V. Egorova, et al.
Published: (2019)